<qa>  What is the objective response rate in patients with stage IIIB or IV bronchoalveI. Determine the objective response rate in patients with stage IIIB or IV bronchoalveolar carcinoma BAC or adencarcinoma of the lung with BAC features treated with bortezomib. 